世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

MEA電子臨床ソリューション市場 - 2030年までの産業動向と予測


MEA E-Clinical Solutions Market - Industry Trends and Forecast to 2030

中東・アフリカのe-クリニカル・ソリューション市場は、2022年の72億7,706万米ドルから2030年には200億2,242万米ドルに達し、2023年から2030年までの予測期間中に年平均成長率13.5％で成長すると予測される。 ... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 言語
Data Bridge Market Research
データブリッジマーケットリサーチ 		2023年5月1日 US$3,500
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		183 英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


　

サマリー

中東・アフリカのe-クリニカル・ソリューション市場は、2022年の72億7,706万米ドルから2030年には200億2,242万米ドルに達し、2023年から2030年までの予測期間中に年平均成長率13.5％で成長すると予測される。

市場細分化：
中東およびアフリカのe-クリニカルソリューション市場：製品別（電子データ収集および臨床データ管理システム、無作為化および試験供給管理、臨床試験管理システム、電子試験マスターファイルシステム、電子臨床アウトカム評価ソリューション、安全性ソリューション、規制情報管理ソリューション、臨床データ統合プラットフォーム、臨床分析プラットフォーム、ケアコーディネーション医療記録（CCMR）、その他）、提供形態別（ウェブホスティング（オンデマンド）ソリューション、クラウドベース（SaaS）ソリューション、ライセンスエンタープライズ（オンプレミス）ソリューション）、臨床試験フェーズ（フェーズI、フェーズII、フェーズIII、フェーズIV）、組織規模（中小規模、大規模）、ユーザーデバイス（デスクトップ、タブレット、スマートフォン、ハンドヘルドPDAデバイス、その他）、エンドユーザー（開発業務受託機関、製薬・バイオ製薬企業、医療機器メーカー、病院、コンサルティングサービス企業、学術研究機関）業界動向と2030年までの予測。


中東およびアフリカのeクリニカルソリューション市場ダイナミクスの概要：

促進要因
- 臨床試験におけるe-クリニカルソリューションの利用拡大
抑制要因

- データの安全性とプライバシーの問題
機会

- 電子データキャプチャ（EDC）システムとクラウドベースのソリューションの採用増加

市場プレイヤー
中東・アフリカの電子臨床ソリューション市場で事業を展開する主な市場プレーヤーを以下に示す：

- オラクル
- ダッソー・システムズ
- パレクセル・インターナショナル
- 4Gクリニカル
- ヴィーヴァ・システムズ
- データトラック・インターナショナル
- IQVIA Inc.


ページTOPに戻る


目次

TABLE OF CONTENTS
1 INTRODUCTION 24
1.1 OBJECTIVES OF THE STUDY 24
1.2 MARKET DEFINITION 24
1.3 OVERVIEW 24
1.4 CURRENCY AND PRICING 26
1.5 LIMITATIONS 26
1.6 MARKETS COVERED 26
2 MARKET SEGMENTATION 29
2.1 MARKETS COVERED 29
2.2 GEOGRAPHICAL SCOPE 30
2.3 YEARS CONSIDERED FOR THE STUDY 31
2.4 DBMR TRIPOD DATA VALIDATION MODEL 32
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 35
2.6 MULTIVARIATE MODELLING 36
2.7 MARKET END USER COVERAGE GRID 37
2.8 PRODUCT LIFELINE CURVE 38
2.9 DBMR MARKET POSITION GRID 39
2.10 VENDOR SHARE ANALYSIS 40
2.11 SECONDARY SOURCES 41
2.12 ASSUMPTIONS 41
3 EXECUTIVE SUMMARY 42
4 PREMIUM INSIGHTS 45
4.1 PORTER'S FIVE FORCES MODEL 46
4.2 ECOSYSTEMS ANALYSIS OF E CLINICAL SOLUTIONS 47
4.3 USE CASES 49
5 VALUE CHAIN ANALYSIS 50
6 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: REGULATIONS 51
7 MARKET OVERVIEW 57
7.1 DRIVERS 59
7.1.1 THE GROWING USAGE OF E-CLINICAL SOLUTIONS IN CLINICAL TRIALS 59
7.1.2 INCREASING R&D ACTIVITIES AND CORRESPONDING EXPENDITURE 59
7.1.3 STRATEGIC INITIATIVES TAKEN BY MAJOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES 60
7.1.4 IMPROVED HEALTHCARE INFRASTRUCTURE AND ESTABLISHMENT OF ADVANCED LABORATORIES 60
7.2 RESTRAINTS 61
7.2.1 DATA SAFETY AND PRIVACY ISSUES 61
7.2.2 LACK OF SKILLED PROFESSIONALS 61
7.2.3 LIMITED ADOPTION OF E-CLINICAL SOLUTIONS IN EMERGING COUNTRIES DUE TO BUDGETARY CONSTRAINTS AND POOR MANAGEMENT POLICIES 62
7.3 OPPORTUNITIES 62
7.3.1 RISING ADOPTION OF ELECTRONIC DATA CAPTURE (EDC) SYSTEMS AND CLOUD-BASED SOLUTIONS 62
7.3.2 INCREASING INVESTMENTS BY VARIOUS GOVERNMENTS IN CLINICAL TRIALS 63
7.3.3 GROWING FOCUS ON PATIENT-CENTRIC CLINICAL TRIALS 63
7.4 CHALLENGES 64
7.4.1 REGULATORY CHALLENGES ASSOCIATED WITH E-CLINICAL SOLUTIONS 64
7.4.2 HIGH IMPLEMENTATION COSTS 64
8 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, BY PRODUCT 66
8.1 OVERVIEW 67
8.2 ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS 70
8.3 RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT 71
8.4 CLINICAL TRIAL MANAGEMENT SYSTEMS 72
8.5 ELECTRONIC TRIAL MASTER FILE SYSTEMS 73
8.6 ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS 74
8.7 SAFETY SOLUTIONS 75
8.8 REGULATORY INFORMATION MANAGEMENT SOLUTIONS 76
8.9 CLINICAL DATA INTEGRATION PLATFORMS 77
8.10 CLINICAL ANALYTICS PLATFORMS 78
8.11 CARE COORDINATION MEDICAL RECORD (CCMR) 79
8.12 OTHERS 80
9 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE 82
9.1 OVERVIEW 83
9.2 WEB-HOSTED (ON-DEMAND) SOLUTIONS 86
9.3 CLOUD-BASED (SAAS) SOLUTIONS 86
9.4 LICENSED ENTERPRISE (ON-PREMISES) SOLUTIONS 87
10 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE 89
10.1 OVERVIEW 90
10.2 PHASE III 93
10.3 PHASE I 93
10.4 PHASE II 94
10.5 PHASE IV 95
11 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE 96
11.1 OVERVIEW 97
11.2 MEDIUM AND SMALL 100
11.3 LARGE 101
12 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE 102
12.1 OVERVIEW 103
12.2 DESKTOP 106
12.3 TABLET 106
12.4 SMART PHONE 107
12.5 HANDHELD PDA DEVICE 108
12.6 OTHERS 108
13 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, BY END USER 110
13.1 OVERVIEW 111
13.2 CONTRACT RESEARCH ORGANIZATIONS 114
13.3 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES 114
13.4 MEDICAL DEVICE MANUFACTURERS 115
13.5 HOSPITAL 116
13.6 CONSULTING SERVICE COMPANIES 116
13.7 ACADEMIC RESEARCH INSTITUTES 117
14 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, BY REGION 118
14.1 MIDDLE EAST AND AFRICA 119
14.1.1 SOUTH AFRICA 126
14.1.2 SAUDI ARABIA 129
14.1.3 U.A.E. 132
14.1.4 EGYPT 135
14.1.5 ISRAEL 138
14.1.6 REST OF MIDDLE EAST AND AFRICA 141
15 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, COMPANY LANDSCAPE 142
15.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 142
16 SWOT ANALYSIS 143
17 COMPANY PROFILE 144
17.1 ORACLE 144
17.1.1 COMPANY SNAPSHOT 144
17.1.2 REVENUE ANALYSIS 144
17.1.3 COMPANY SHARE ANALYSIS 145
17.1.4 PRODUCT PORTFOLIO 145
17.1.5 RECENT DEVELOPMENT 145
17.2 DASSAULT SYSTEMES 146
17.2.1 COMPANY SNAPSHOT 146
17.2.2 REVENUE ANALYSIS 146
17.2.3 COMPANY SHARE ANALYSIS 147
17.2.4 PRODUCT PORTFOLIO 147
17.2.5 RECENT DEVELOPMENTS 148
17.3 CLARIO 149
17.3.1 COMPANY SNAPSHOT 149
17.3.2 COMPANY SHARE ANALYSIS 149
17.3.3 PRODUCT PORTFOLIO 150
17.3.4 RECENT DEVELOPMENT 150
17.4 VEEVA SYSTEMS 151
17.4.1 COMPANY SNAPSHOT 151
17.4.2 REVENUE ANALYSIS 151
17.4.3 COMPANY SHARE ANALYSIS 152
17.4.4 PRODUCT PORTFOLIO 152
17.4.5 RECENT DEVELOPMENTS 153
17.5 ARISMIDDLE EAST & AFRICA 154
17.5.1 COMPANY SNAPSHOT 154
17.5.2 COMPANY SHARE ANALYSIS 154
17.5.3 PRODUCT PORTFOLIO 155
17.5.4 RECENT DEVELOPMENTS 155
17.6 4G CLINICAL 156
17.6.1 COMPANY SNAPSHOT 156
17.6.2 PRODUCT PORTFOLIO 156
17.6.3 RECENT DEVELOPMENT 156
17.7 ADVARRA. 157
17.7.1 COMPANY SNAPSHOT 157
17.7.2 PRODUCT PORTFOLIO 157
17.7.3 RECENT DEVELOPMENT 157
17.8 ANJU 158
17.8.1 COMPANY SNAPSHOT 158
17.8.2 PRODUCT PORTFOLIO 158
17.8.3 RECENT DEVELOPMENTS 159
17.9 CASTOR. 160
17.9.1 COMPANY SNAPSHOT 160
17.9.2 PRODUCT PORTFOLIO 160
17.9.3 RECENT DEVELOPMENTS 160
17.10 DATATRAK INT. 161
17.10.1 COMPANY SNAPSHOT 161
17.10.2 PRODUCT PORTFOLIO 161
17.10.3 RECENT DEVELOPMENT 161
17.11 ECLINICAL SOLUTIONS LLC. 162
17.11.1 COMPANY SNAPSHOT 162
17.11.2 PRODUCT PORTFOLIO 162
17.11.3 RECENT DEVELOPMENT 162
17.12 IQVIA INC 163
17.12.1 COMPANY SNAPSHOT 163
17.12.2 REVENUE ANALYSIS 163
17.12.3 PRODUCT PORTFOLIO 164
17.12.4 RECENT DEVELOPMENTS 164
17.13 MAXISIT 165
17.13.1 COMPANY SNAPSHOT 165
17.13.2 PRODUCT PORTFOLIO 165
17.13.3 RECENT DEVELOPMENT 166
17.14 MEDNET 167
17.14.1 COMPANY SNAPSHOT 167
17.14.2 PRODUCT PORTFOLIO 167
17.14.3 RECENT DEVELOPMENT 168
17.15 MEDRIO, INC. 169
17.15.1 COMPANY SNAPSHOT 169
17.15.2 PRODUCT PORTFOLIO 169
17.15.3 RECENT DEVELOPMENTS 170
17.16 MERATIVE 171
17.16.1 COMPANY SNAPSHOT 171
17.16.2 PRODUCT PORTFOLIO 171
17.16.3 RECENT DEVELOPMENT 171
17.17 OPENCLINICA, LLC 172
17.17.1 COMPANY SNAPSHOT 172
17.17.2 PRODUCT PORTFOLIO 172
17.17.3 RECENT DEVELOPMENT 172
17.18 PAREXEL INTERNATIONAL CORPORATION 173
17.18.1 COMPANY SNAPSHOT 173
17.18.2 PRODUCT PORTFOLIO 173
17.18.3 RECENT DEVELOPMENT 173
17.19 QURETEC 174
17.19.1 COMPANY SNAPSHOT 174
17.19.2 PRODUCT PORTFOLIO 174
17.19.3 RECENT DEVELOPMENT 174
17.20 REALTIME SOFTWARE SOLUTIONS, LLC 175
17.20.1 COMPANY SNAPSHOT 175
17.20.2 PRODUCT PORTFOLIO 175
17.20.3 RECENT DEVELOPMENT 175
17.21 RESEARCH MANAGER 176
17.21.1 COMPANY SNAPSHOT 176
17.21.2 PRODUCT PORTFOLIO 176
17.21.3 RECENT DEVELOPMENT 176
17.22 SAAMA TECHNOLOGIES, LLC 177
17.22.1 COMPANY SNAPSHOT 177
17.22.2 PRODUCT PORTFOLIO 177
17.22.3 RECENT DEVELOPMENT 177
17.23 SIGNANT HEALTH 178
17.23.1 COMPANY SNAPSHOT 178
17.23.2 PRODUCT PORTFOLIO 178
17.23.3 RECENT DEVELOPMENT 178
17.24 Y-PRIME, LLC. 179
17.24.1 COMPANY SNAPSHOT 179
17.24.2 PRODUCT PORTFOLIO 179
17.24.3 RECENT DEVELOPMENT 179
18 QUESTIONNAIRE 180
19 RELATED REPORTS 183

　

ページTOPに戻る


　

Summary

Middle East and Africa e-clinical solutions market is expected to reach USD 20,022.42 million by 2030 from USD 7,270.06 million in 2022, growing with a CAGR of 13.5% during the forecast period from 2023 to 2030.

Market Segmentation:
Middle East and Africa e-Clinical Solutions Market, By Product (Electronic Data Capture and Clinical Data Management Systems, Randomization and Trial Supply Management, Clinical Trial Management Systems, Electronic Trial Master File Systems, Electronic Clinical Outcome Assessment Solutions, Safety Solutions, Regulatory Information Management Solutions, Clinical Data Integration Platforms, Clinical Analytics Platforms, Care Coordination Medical Record (CCMR), and Others), Delivery Mode (Web-Hosted (On-Demand) Solutions, Cloud-Based (SaaS) Solutions, and Licensed Enterprise (On-Premises) Solutions), Clinical Trial Phase (Phase I, Phase II, Phase III, and Phase IV), Organization Size (Medium and small, and Large), User Device (Desktop, Tablet, Smart Phone, Handheld PDA Device, and Others), End User (Contract Research Organizations, Pharmaceutical and Biopharmaceutical Companies, Medical Device Manufacturers, Hospital, Consulting Service Companies, and Academic Research Institutes) Industry Trends and Forecast to 2030.


Overview of Middle East and Africa e-Clinical Solutions Market Dynamics:

Driver
• The growing usage of e-clinical solutions in clinical trials
Restraint

• Data safety and privacy issues
Opportunity

• Rising adoption of electronic data capture (EDC) systems and cloud-based solutions

Market Players:
Some of the key market players operating in the Middle East and Africa e-clinical solutions market are listed below:

• Oracle
• Dassault Systèmes
• PAREXEL INTERNATIONAL CORPORATION
• 4G Clinical
• Veeva Systems
• Datatrak Int.
• IQVIA Inc



ページTOPに戻る


Table of Contents

TABLE OF CONTENTS
1 INTRODUCTION 24
1.1 OBJECTIVES OF THE STUDY 24
1.2 MARKET DEFINITION 24
1.3 OVERVIEW 24
1.4 CURRENCY AND PRICING 26
1.5 LIMITATIONS 26
1.6 MARKETS COVERED 26
2 MARKET SEGMENTATION 29
2.1 MARKETS COVERED 29
2.2 GEOGRAPHICAL SCOPE 30
2.3 YEARS CONSIDERED FOR THE STUDY 31
2.4 DBMR TRIPOD DATA VALIDATION MODEL 32
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 35
2.6 MULTIVARIATE MODELLING 36
2.7 MARKET END USER COVERAGE GRID 37
2.8 PRODUCT LIFELINE CURVE 38
2.9 DBMR MARKET POSITION GRID 39
2.10 VENDOR SHARE ANALYSIS 40
2.11 SECONDARY SOURCES 41
2.12 ASSUMPTIONS 41
3 EXECUTIVE SUMMARY 42
4 PREMIUM INSIGHTS 45
4.1 PORTER'S FIVE FORCES MODEL 46
4.2 ECOSYSTEMS ANALYSIS OF E CLINICAL SOLUTIONS 47
4.3 USE CASES 49
5 VALUE CHAIN ANALYSIS 50
6 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: REGULATIONS 51
7 MARKET OVERVIEW 57
7.1 DRIVERS 59
7.1.1 THE GROWING USAGE OF E-CLINICAL SOLUTIONS IN CLINICAL TRIALS 59
7.1.2 INCREASING R&D ACTIVITIES AND CORRESPONDING EXPENDITURE 59
7.1.3 STRATEGIC INITIATIVES TAKEN BY MAJOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES 60
7.1.4 IMPROVED HEALTHCARE INFRASTRUCTURE AND ESTABLISHMENT OF ADVANCED LABORATORIES 60
7.2 RESTRAINTS 61
7.2.1 DATA SAFETY AND PRIVACY ISSUES 61
7.2.2 LACK OF SKILLED PROFESSIONALS 61
7.2.3 LIMITED ADOPTION OF E-CLINICAL SOLUTIONS IN EMERGING COUNTRIES DUE TO BUDGETARY CONSTRAINTS AND POOR MANAGEMENT POLICIES 62
7.3 OPPORTUNITIES 62
7.3.1 RISING ADOPTION OF ELECTRONIC DATA CAPTURE (EDC) SYSTEMS AND CLOUD-BASED SOLUTIONS 62
7.3.2 INCREASING INVESTMENTS BY VARIOUS GOVERNMENTS IN CLINICAL TRIALS 63
7.3.3 GROWING FOCUS ON PATIENT-CENTRIC CLINICAL TRIALS 63
7.4 CHALLENGES 64
7.4.1 REGULATORY CHALLENGES ASSOCIATED WITH E-CLINICAL SOLUTIONS 64
7.4.2 HIGH IMPLEMENTATION COSTS 64
8 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, BY PRODUCT 66
8.1 OVERVIEW 67
8.2 ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS 70
8.3 RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT 71
8.4 CLINICAL TRIAL MANAGEMENT SYSTEMS 72
8.5 ELECTRONIC TRIAL MASTER FILE SYSTEMS 73
8.6 ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS 74
8.7 SAFETY SOLUTIONS 75
8.8 REGULATORY INFORMATION MANAGEMENT SOLUTIONS 76
8.9 CLINICAL DATA INTEGRATION PLATFORMS 77
8.10 CLINICAL ANALYTICS PLATFORMS 78
8.11 CARE COORDINATION MEDICAL RECORD (CCMR) 79
8.12 OTHERS 80
9 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE 82
9.1 OVERVIEW 83
9.2 WEB-HOSTED (ON-DEMAND) SOLUTIONS 86
9.3 CLOUD-BASED (SAAS) SOLUTIONS 86
9.4 LICENSED ENTERPRISE (ON-PREMISES) SOLUTIONS 87
10 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE 89
10.1 OVERVIEW 90
10.2 PHASE III 93
10.3 PHASE I 93
10.4 PHASE II 94
10.5 PHASE IV 95
11 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE 96
11.1 OVERVIEW 97
11.2 MEDIUM AND SMALL 100
11.3 LARGE 101
12 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE 102
12.1 OVERVIEW 103
12.2 DESKTOP 106
12.3 TABLET 106
12.4 SMART PHONE 107
12.5 HANDHELD PDA DEVICE 108
12.6 OTHERS 108
13 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, BY END USER 110
13.1 OVERVIEW 111
13.2 CONTRACT RESEARCH ORGANIZATIONS 114
13.3 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES 114
13.4 MEDICAL DEVICE MANUFACTURERS 115
13.5 HOSPITAL 116
13.6 CONSULTING SERVICE COMPANIES 116
13.7 ACADEMIC RESEARCH INSTITUTES 117
14 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, BY REGION 118
14.1 MIDDLE EAST AND AFRICA 119
14.1.1 SOUTH AFRICA 126
14.1.2 SAUDI ARABIA 129
14.1.3 U.A.E. 132
14.1.4 EGYPT 135
14.1.5 ISRAEL 138
14.1.6 REST OF MIDDLE EAST AND AFRICA 141
15 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, COMPANY LANDSCAPE 142
15.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 142
16 SWOT ANALYSIS 143
17 COMPANY PROFILE 144
17.1 ORACLE 144
17.1.1 COMPANY SNAPSHOT 144
17.1.2 REVENUE ANALYSIS 144
17.1.3 COMPANY SHARE ANALYSIS 145
17.1.4 PRODUCT PORTFOLIO 145
17.1.5 RECENT DEVELOPMENT 145
17.2 DASSAULT SYSTEMES 146
17.2.1 COMPANY SNAPSHOT 146
17.2.2 REVENUE ANALYSIS 146
17.2.3 COMPANY SHARE ANALYSIS 147
17.2.4 PRODUCT PORTFOLIO 147
17.2.5 RECENT DEVELOPMENTS 148
17.3 CLARIO 149
17.3.1 COMPANY SNAPSHOT 149
17.3.2 COMPANY SHARE ANALYSIS 149
17.3.3 PRODUCT PORTFOLIO 150
17.3.4 RECENT DEVELOPMENT 150
17.4 VEEVA SYSTEMS 151
17.4.1 COMPANY SNAPSHOT 151
17.4.2 REVENUE ANALYSIS 151
17.4.3 COMPANY SHARE ANALYSIS 152
17.4.4 PRODUCT PORTFOLIO 152
17.4.5 RECENT DEVELOPMENTS 153
17.5 ARISMIDDLE EAST & AFRICA 154
17.5.1 COMPANY SNAPSHOT 154
17.5.2 COMPANY SHARE ANALYSIS 154
17.5.3 PRODUCT PORTFOLIO 155
17.5.4 RECENT DEVELOPMENTS 155
17.6 4G CLINICAL 156
17.6.1 COMPANY SNAPSHOT 156
17.6.2 PRODUCT PORTFOLIO 156
17.6.3 RECENT DEVELOPMENT 156
17.7 ADVARRA. 157
17.7.1 COMPANY SNAPSHOT 157
17.7.2 PRODUCT PORTFOLIO 157
17.7.3 RECENT DEVELOPMENT 157
17.8 ANJU 158
17.8.1 COMPANY SNAPSHOT 158
17.8.2 PRODUCT PORTFOLIO 158
17.8.3 RECENT DEVELOPMENTS 159
17.9 CASTOR. 160
17.9.1 COMPANY SNAPSHOT 160
17.9.2 PRODUCT PORTFOLIO 160
17.9.3 RECENT DEVELOPMENTS 160
17.10 DATATRAK INT. 161
17.10.1 COMPANY SNAPSHOT 161
17.10.2 PRODUCT PORTFOLIO 161
17.10.3 RECENT DEVELOPMENT 161
17.11 ECLINICAL SOLUTIONS LLC. 162
17.11.1 COMPANY SNAPSHOT 162
17.11.2 PRODUCT PORTFOLIO 162
17.11.3 RECENT DEVELOPMENT 162
17.12 IQVIA INC 163
17.12.1 COMPANY SNAPSHOT 163
17.12.2 REVENUE ANALYSIS 163
17.12.3 PRODUCT PORTFOLIO 164
17.12.4 RECENT DEVELOPMENTS 164
17.13 MAXISIT 165
17.13.1 COMPANY SNAPSHOT 165
17.13.2 PRODUCT PORTFOLIO 165
17.13.3 RECENT DEVELOPMENT 166
17.14 MEDNET 167
17.14.1 COMPANY SNAPSHOT 167
17.14.2 PRODUCT PORTFOLIO 167
17.14.3 RECENT DEVELOPMENT 168
17.15 MEDRIO, INC. 169
17.15.1 COMPANY SNAPSHOT 169
17.15.2 PRODUCT PORTFOLIO 169
17.15.3 RECENT DEVELOPMENTS 170
17.16 MERATIVE 171
17.16.1 COMPANY SNAPSHOT 171
17.16.2 PRODUCT PORTFOLIO 171
17.16.3 RECENT DEVELOPMENT 171
17.17 OPENCLINICA, LLC 172
17.17.1 COMPANY SNAPSHOT 172
17.17.2 PRODUCT PORTFOLIO 172
17.17.3 RECENT DEVELOPMENT 172
17.18 PAREXEL INTERNATIONAL CORPORATION 173
17.18.1 COMPANY SNAPSHOT 173
17.18.2 PRODUCT PORTFOLIO 173
17.18.3 RECENT DEVELOPMENT 173
17.19 QURETEC 174
17.19.1 COMPANY SNAPSHOT 174
17.19.2 PRODUCT PORTFOLIO 174
17.19.3 RECENT DEVELOPMENT 174
17.20 REALTIME SOFTWARE SOLUTIONS, LLC 175
17.20.1 COMPANY SNAPSHOT 175
17.20.2 PRODUCT PORTFOLIO 175
17.20.3 RECENT DEVELOPMENT 175
17.21 RESEARCH MANAGER 176
17.21.1 COMPANY SNAPSHOT 176
17.21.2 PRODUCT PORTFOLIO 176
17.21.3 RECENT DEVELOPMENT 176
17.22 SAAMA TECHNOLOGIES, LLC 177
17.22.1 COMPANY SNAPSHOT 177
17.22.2 PRODUCT PORTFOLIO 177
17.22.3 RECENT DEVELOPMENT 177
17.23 SIGNANT HEALTH 178
17.23.1 COMPANY SNAPSHOT 178
17.23.2 PRODUCT PORTFOLIO 178
17.23.3 RECENT DEVELOPMENT 178
17.24 Y-PRIME, LLC. 179
17.24.1 COMPANY SNAPSHOT 179
17.24.2 PRODUCT PORTFOLIO 179
17.24.3 RECENT DEVELOPMENT 179
18 QUESTIONNAIRE 180
19 RELATED REPORTS 183

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医薬）の最新刊レポート

Data Bridge Market Research社の医薬分野での最新刊レポート

本レポートと同じKEY WORD（mea）の最新刊レポート


よくあるご質問


Data Bridge Market Research社はどのような調査会社ですか?


データブリッジマーケットリサーチ(Data Bridge Market Research)は500名以上の多様な分野のアナリストが所属するインドの調査会社です。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/12/20　10:28

158.95 円

165.20 円

201.28 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.